Matching slides 78,138
Current window 65,191-65,220
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

65,191-65,220 of 78,138

filter-aware
27
The chart uses a stacked bar approach to show the components of FX impact.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
30
The chart uses a standard waterfall bridge to decompose the change in EPS.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
05
The slide uses a Gantt-style chart to represent clinical trial progress.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
09
The slide uses a KINOMEscan visualization to show selectivity.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
10
The chart is a classic waterfall plot used in oncology to show best response per patient/model.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
14
The chart shows lower IC50 values for the Q61X mutation group, suggesting higher sensitivity to the drug.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
16
Includes a Kaplan-Meier survival curve comparing existing standard-of-care options.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
19
The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
20
The slide uses a 2D grid to map dose combinations against regulatory requirements (Project Optimus).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
24
The chart is a Kaplan-Meier survival curve comparing a control arm to an experimental arm (EC).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM compared to other indications.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
32
The chart is a Kaplan-Meier survival plot comparing three treatment groups.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
41
The slide uses a log-scale line chart for PK profiles and a summary table for key metrics (Cmax, Cmin, T>IC90, T<IC50).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
09
Uses a waterfall chart to explain sales growth and circular callouts for key performance indicators.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide uses a callout circle to emphasize the current proposed dividend and an arrow overlay to visualize the growth trend.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
14
The chart uses a standard waterfall bridge format to explain sales growth components.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
15
The chart uses a waterfall-bridge structure to explain margin variance.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
17
The waterfall chart uses a break in the axis to represent the growth components between the two net sales bars.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
19
Uses a waterfall-bridge chart to explain the change in Net Sales.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
21
The slide uses a waterfall-style bridge to explain sales growth, followed by two circular callouts for profitability metrics.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
25
The slide uses a brand-specific image of a baby to reinforce the 'Libero' brand context.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
10
The slide uses a horizontal bar chart structure to represent clinical development stages.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
20
Uses information theory to explain why 20 binary questions can narrow down a search space of 600,000 items.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
21
The chart uses a series of iterative loop icons to represent the learning process.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
22
The scatter plot highlights a specific cluster of compounds (labeled 1 and 2) that were selected by the active learning model despite being outside the typical high-potency/high-score Pareto frontier.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
24
The slide uses a process flow diagram to connect target criteria to computational optimization and final project telemetry.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
26
The slide features a 3D molecular model and a set of circular gauges representing various drug discovery metrics (potency, stability, toxicity, etc.).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a process flow diagram to illustrate a specific patient journey.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit